These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 33569062)
21. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients. Hong T; Zhang M; Fan J Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009698. PubMed ID: 26457607 [TBL] [Abstract][Full Text] [Related]
22. Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy. Chiarelli LR; Molinaro M; Libetta C; Tinelli C; Cosmai L; Valentini G; Dal Canton A; Regazzi M Br J Clin Pharmacol; 2010 Jan; 69(1):38-50. PubMed ID: 20078611 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report. Brunet M; van Gelder T; Åsberg A; Haufroid V; Hesselink DA; Langman L; Lemaitre F; Marquet P; Seger C; Shipkova M; Vinks A; Wallemacq P; Wieland E; Woillard JB; Barten MJ; Budde K; Colom H; Dieterlen MT; Elens L; Johnson-Davis KL; Kunicki PK; MacPhee I; Masuda S; Mathew BS; Millán O; Mizuno T; Moes DAR; Monchaud C; Noceti O; Pawinski T; Picard N; van Schaik R; Sommerer C; Vethe NT; de Winter B; Christians U; Bergan S Ther Drug Monit; 2019 Jun; 41(3):261-307. PubMed ID: 31045868 [TBL] [Abstract][Full Text] [Related]
24. Trans-vivo delayed type hypersensitivity assay for antigen specific regulation. Jankowska-Gan E; Hegde S; Burlingham WJ J Vis Exp; 2013 May; (75):e4454. PubMed ID: 23665523 [TBL] [Abstract][Full Text] [Related]
25. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor. Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718 [TBL] [Abstract][Full Text] [Related]
26. Monitoring of immunosuppressive therapy in renal transplanted patients. Chiaramonte S; Dissegna D; Ronco C Contrib Nephrol; 2005; 146():73-86. PubMed ID: 15567922 [TBL] [Abstract][Full Text] [Related]
27. Immune functional assay for immunosuppressive management in post-transplant malignancy. Uemura T; Riley TR; Khan A; Hollenbeak C; Schreibman I; Ghahramani N; Reeves B; Domen RE; Zander DS; Kadry Z Clin Transplant; 2011; 25(1):E32-7. PubMed ID: 20636411 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of Histone Deacetylase 6 Reveals a Potent Immunosuppressant Effect in Models of Transplantation. Ellis JD; Neil DA; Inston NG; Jenkinson E; Drayson MT; Hampson P; Shuttleworth SJ; Ready AR; Cobbold M Transplantation; 2016 Aug; 100(8):1667-74. PubMed ID: 27222932 [TBL] [Abstract][Full Text] [Related]
29. Personalized treatment in heart transplantation. Khush KK Curr Opin Organ Transplant; 2017 Jun; 22(3):215-220. PubMed ID: 28266942 [TBL] [Abstract][Full Text] [Related]
30. Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation. He J; Li Y; Zhang H; Wei X; Zheng H; Xu C; Bao X; Yuan X; Hou J Clin Transplant; 2013; 27(4):E351-8. PubMed ID: 23682828 [TBL] [Abstract][Full Text] [Related]
31. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium. Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729 [TBL] [Abstract][Full Text] [Related]
33. Immunity after organ transplantation. Villard J Swiss Med Wkly; 2006 Feb; 136(5-6):71-7. PubMed ID: 16633949 [TBL] [Abstract][Full Text] [Related]
34. Pre-transplant donor-specific T-cell alloreactivity is strongly associated with early acute cellular rejection in kidney transplant recipients not receiving T-cell depleting induction therapy. Crespo E; Lucia M; Cruzado JM; Luque S; Melilli E; Manonelles A; Lloberas N; Torras J; Grinyó JM; Bestard O PLoS One; 2015; 10(2):e0117618. PubMed ID: 25689405 [TBL] [Abstract][Full Text] [Related]
35. Optimization of immunosuppressive therapy based on a multiparametric mixed lymphocyte reaction assay reduces infectious complications and mortality in living donor liver transplant recipients. Tanaka Y; Tashiro H; Onoe T; Ide K; Ishiyama K; Ohdan H Transplant Proc; 2012 Mar; 44(2):555-9. PubMed ID: 22410068 [TBL] [Abstract][Full Text] [Related]
36. Immunosuppression in the era of biological agents. Grinyó JM; Cruzado JM; Bestard O; Vidal Castiñeira JR; Torras J Adv Exp Med Biol; 2012; 741():60-72. PubMed ID: 22457103 [TBL] [Abstract][Full Text] [Related]
37. Mycophenolic acid concentrations in peripheral blood mononuclear cells are associated with the incidence of rejection in renal transplant recipients. Md Dom ZI; Coller JK; Carroll RP; Tuke J; McWhinney BC; Somogyi AA; Sallustio BC Br J Clin Pharmacol; 2018 Oct; 84(10):2433-2442. PubMed ID: 29974488 [TBL] [Abstract][Full Text] [Related]
38. Risk factors for and management of post-transplantation cardiovascular disease. Fellström B BioDrugs; 2001; 15(4):261-78. PubMed ID: 11437691 [TBL] [Abstract][Full Text] [Related]
39. Administration of Antithymocyte Globulin (Rabbit) to Treat a Severe, Mixed Rejection Episode in a Pregnant Renal Transplant Recipient. Kutzler HL; Ye X; Rochon C; Martin ST Pharmacotherapy; 2016 Apr; 36(4):e18-22. PubMed ID: 26892892 [TBL] [Abstract][Full Text] [Related]
40. Clinical relevance of post-transplant pharmacodynamic analysis of cyclosporine in renal transplantation. Kurata Y; Kuzuya T; Miwa Y; Iwasaki K; Haneda M; Amioka K; Yamada K; Watarai Y; Katayama A; Uchida K; Kobayashi T Int Immunopharmacol; 2014 Oct; 22(2):384-91. PubMed ID: 25073119 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]